Variation of Human Immunodeficiency Virus Type-1 Reverse Transcriptase within the Simian Immunodeficiency Virus Genome of RT-SHIV

被引:1
作者
Wadford, Debra A. [1 ]
Kauffman, Robert C. [1 ]
Deere, Jesse D. [1 ]
Aoki, Scott T. [1 ]
Stanton, Richard A. [2 ,3 ]
Higgins, Joanne [1 ]
Van Rompay, Koen K. A. [4 ]
Villalobos, Andradi [1 ]
Nettles, James H. [2 ,3 ]
Schinazi, Raymond F. [5 ]
Pedersen, Niels C. [6 ]
North, Thomas W. [1 ,7 ]
机构
[1] Univ Calif Davis, Ctr Comparat Med, Davis, CA 95616 USA
[2] Emory Univ, Sch Med, Dept Pediat, Childrens Ctr Drug Discovery CDD, Atlanta, GA USA
[3] Emory Univ, Sch Med, Dept Biomed Informat, Atlanta, GA USA
[4] Univ Calif Davis, Calif Natl Primate Res Ctr, Davis, CA 95616 USA
[5] Emory Univ, Sch Med, Vet Affairs Med Ctr, Decatur, GA 30033 USA
[6] Univ Calif Davis, Dept Med & Epidemiol, Sch Vet Med, Davis, CA 95616 USA
[7] Univ Calif Davis, Dept Mol Biosci, Sch Vet Med, Davis, CA 95616 USA
关键词
HIV-1 NUCLEOCAPSID PROTEIN; ACTIVE ANTIRETROVIRAL THERAPY; RHESUS MACAQUES; SEQUENCE VARIATION; DRUG-RESISTANCE; VIRAL DYNAMICS; IN-VITRO; INFECTED MACAQUES; STRAND TRANSFER; M184V MUTATION;
D O I
10.1371/journal.pone.0086997
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
RT-SHIV is a chimera of simian immunodeficiency virus (SIV) containing the reverse transcriptase (RT)-encoding region of human immunodeficiency virus type 1 (HIV-1) within the backbone of SIVmac239. It has been used in a non-human primate model for studies of non-nucleoside RT inhibitors (NNRTI) and highly active antiretroviral therapy (HAART). We and others have identified several mutations that arise in the "foreign" HIV-1 RT of RT-SHIV during in vivo replication. In this study we catalogued amino acid substitutions in the HIV-1 RT and in regions of the SIV backbone with which RT interacts that emerged 30 weeks post-infection from seven RT-SHIV-infected rhesus macaques. The virus set points varied from relatively high virus load, moderate virus load, to undetectable virus load. The G196R substitution in RT was detected from 6 of 7 animals at week 4 post-infection and remained in virus from 4 of 6 animals at week 30. Virus from four high virus load animals showed several common mutations within RT, including L74V or V75L, G196R, L214F, and K275R. The foreign RT from high virus load isolates exhibited as much variation as that of the highly variable envelope surface glycoprotein, and 10-fold higher than that of the native RT of SIVmac239. Isolates from moderate virus load animals showed much less variation in the foreign RT than the high virus load isolates. No variation was found in SIVmac239 genes known to interact with RT. Our results demonstrate substantial adaptation of the foreign HIV-1 RT in RT-SHIV-infected macaques, which most likely reflects selective pressure upon the foreign RT to attain optimal activity within the context of the chimeric RT-SHIV and the rhesus macaque host.
引用
收藏
页数:14
相关论文
共 81 条
[31]  
Gardner MB., 2004, AIDS and other manifestations of HIV infection, V4th, P195
[32]   GENOMIC DIVERSITY OF THE ACQUIRED IMMUNE-DEFICIENCY SYNDROME VIRUS HTLV-III - DIFFERENT VIRUSES EXHIBIT GREATEST DIVERGENCE IN THEIR ENVELOPE GENES [J].
HAHN, BH ;
GONDA, MA ;
SHAW, GM ;
POPOVIC, M ;
HOXIE, JA ;
GALLO, RC ;
WONGSTAAL, F .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1985, 82 (14) :4813-4817
[33]   Tat is required for efficient HIV-1 reverse transcription [J].
Harrich, D ;
Ulich, C ;
GarciaMartinez, LF ;
Gaynor, RB .
EMBO JOURNAL, 1997, 16 (06) :1224-1235
[34]   A critical role for the TAR element in promoting efficient human immunodeficiency virus type 1 reverse transcription [J].
Harrich, D ;
Ulich, C ;
Gaynor, RB .
JOURNAL OF VIROLOGY, 1996, 70 (06) :4017-4027
[35]   Viral dynamics of HIV: Implications for drug development and therapeutic strategies [J].
Havlir, DV ;
Richman, DD .
ANNALS OF INTERNAL MEDICINE, 1996, 124 (11) :984-994
[36]   Efavirenz therapy in rhesus macaques infected with a chimera of simian immunodeficiency virus containing reverse transcriptase from human immunodeficiency virus type 1 [J].
Hofman, MJ ;
Higgins, J ;
Matthews, TB ;
Pedersen, NC ;
Tan, C ;
Schinazi, RF ;
North, TW .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (09) :3483-3490
[37]   Structure of a covalently trapped catalytic complex of HIV-I reverse transcriptase: Implications for drug resistance [J].
Huang, HF ;
Chopra, R ;
Verdine, GL ;
Harrison, SC .
SCIENCE, 1998, 282 (5394) :1669-1675
[38]   Effect of human immunodeficiency virus type 1 (HIV-1) nucleocapsid protein on HIV-1 reverse transcriptase activity in vitro [J].
Ji, XD ;
Klarmann, GJ ;
Preston, BD .
BIOCHEMISTRY, 1996, 35 (01) :132-143
[39]   IDENTIFICATION OF TRANSFER-RNAS INCORPORATED INTO WILD-TYPE AND MUTANT HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 [J].
JIANG, M ;
MAK, J ;
LADHA, A ;
COHEN, E ;
KLEIN, M ;
ROVINSKI, B ;
KLEIMAN, L .
JOURNAL OF VIROLOGY, 1993, 67 (06) :3246-3253
[40]   Evolution of human immunodeficiency virus type 1 (HIV-1) resistance mutations in nonnucleoside reverse transcriptase inhibitors (NNRTIs) in HIV-1-infected patients switched to antiretroviral therapy without NNRTIs [J].
Joly, V ;
Descamps, D ;
Peytavin, G ;
Touati, F ;
Mentre, F ;
Duval, X ;
Delarue, S ;
Yeni, P ;
Brun-Vezinet, F .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (01) :172-175